Literature DB >> 28285391

Very Small Embryonic-like Stem Cells Are Mobilized in Human Peripheral Blood during Hypoxemic COPD Exacerbations and Pulmonary Hypertension.

Coralie L Guerin1, Adeline Blandinières2,3,4, Benjamin Planquette2,3,5, Jean-Sébastien Silvestre3,6, Dominique Israel-Biet2,3,5, Olivier Sanchez2,3,5, David M Smadja7,8,9,10.   

Abstract

Very small embryonic-like stem cells (VSELs) are major pluripotent stem cells involved in vascular and tissue regeneration and constitute a recruitable pool of stem/progenitor cells with putative instrumental role in organ repair. Here, we hypothesized that VSELs might be mobilized from the bone marrow (BM) to peripheral blood (PB) in patients with hypoxic lung disease or pulmonary hypertension (PH). The objective of the present study was then to investigate the changes in VSELs number in peripheral blood of patients with hypoxic lung disease and PH. We enrolled 26 patients with Chronic Obstructive Pulmonary Disease (COPD) with or without hypoxemia, 13 patients with PH and 20 controls without any respiratory or cardiovascular diseases. In PH patients, VSELs levels have been determined during right heart catheterization in pulmonary blood and PB. For this purpose, mononuclear cells were separated by density gradient and VSELs have been quantified by using a multiparametric flow cytometry approach. The number of PB-VSELs in hypoxic COPD patients was significantly increased compared with non-hypoxic COPD patients or controls (p = 0.0055). In patients with PH, we did not find any difference in VSELs numbers between arterial pulmonary blood and venous PB (p = 0.93). However, we found an increase in VSELs in the peripheral blood of patients with PH (p = 0.03). In conclusion, we unraveled that circulating VSELs were increased in peripheral blood of patients with hypoxic COPD or with PH. Thus, VSELs may serve as a reservoir of pluripotent stem cells that can be recruited into PB and may play an important role in promoting lung repair.

Entities:  

Keywords:  Hypoxia; Lung; Progenitor cells; Pulmonary hypertension; VSEL; Very small embryonic-like stem cells

Mesh:

Year:  2017        PMID: 28285391     DOI: 10.1007/s12015-017-9732-6

Source DB:  PubMed          Journal:  Stem Cell Rev Rep        ISSN: 2629-3277            Impact factor:   5.739


  45 in total

1.  Identification of bronchioalveolar stem cells in normal lung and lung cancer.

Authors:  Carla F Bender Kim; Erica L Jackson; Amber E Woolfenden; Sharon Lawrence; Imran Babar; Sinae Vogel; Denise Crowley; Roderick T Bronson; Tyler Jacks
Journal:  Cell       Date:  2005-06-17       Impact factor: 41.582

Review 2.  Adult marrow-derived very small embryonic-like stem cells and tissue engineering.

Authors:  Magda Kucia; Ewa K Zuba-Surma; Marcin Wysoczynski; Wan Wu; Janina Ratajczak; Boguslaw Machalinski; Mariusz Z Ratajczak
Journal:  Expert Opin Biol Ther       Date:  2007-10       Impact factor: 4.388

3.  Mouse Bone Marrow VSELs Exhibit Differentiation into Three Embryonic Germ Lineages and Germ & Hematopoietic Cells in Culture.

Authors:  Ambreen Shaikh; Sandhya Anand; Sona Kapoor; Ranita Ganguly; Deepa Bhartiya
Journal:  Stem Cell Rev Rep       Date:  2017-04       Impact factor: 5.739

4.  The Global Emergence of Unregulated Stem Cell Treatments for Respiratory Diseases. Professional Societies Need to Act.

Authors:  Laertis Ikonomou; Robert J Freishtat; Darcy E Wagner; Angela Panoskaltsis-Mortari; Daniel J Weiss
Journal:  Ann Am Thorac Soc       Date:  2016-08

5.  Intermittent hypoxia mobilizes bone marrow-derived very small embryonic-like stem cells and activates developmental transcriptional programs in mice.

Authors:  Sina A Gharib; Ehab A Dayyat; Abdelnaby Khalyfa; Jinkwan Kim; Heather B Clair; Magdalena Kucia; David Gozal
Journal:  Sleep       Date:  2010-11       Impact factor: 5.849

6.  C-kit-positive cells accumulate in remodeled vessels of idiopathic pulmonary arterial hypertension.

Authors:  David Montani; Frédéric Perros; Natalia Gambaryan; Barbara Girerd; Peter Dorfmuller; Laura C Price; Alice Huertas; Hamida Hammad; Bart Lambrecht; Gérald Simonneau; Jean-Marie Launay; Sylvia Cohen-Kaminsky; Marc Humbert
Journal:  Am J Respir Crit Care Med       Date:  2011-02-04       Impact factor: 21.405

7.  Hypoxia-induced pulmonary artery adventitial remodeling and neovascularization: contribution of progenitor cells.

Authors:  Neil J Davie; Joseph T Crossno; Maria G Frid; Stephen E Hofmeister; John T Reeves; Dallas M Hyde; Todd C Carpenter; Jacqueline A Brunetti; Ian K McNiece; Kurt R Stenmark
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2003-05-16       Impact factor: 5.464

Review 8.  Mesenchymal stem cells in the treatment of chronic lung disease.

Authors:  Sophie Wecht; Mauricio Rojas
Journal:  Respirology       Date:  2016-09-29       Impact factor: 6.424

9.  Novel epigenetic mechanisms that control pluripotency and quiescence of adult bone marrow-derived Oct4(+) very small embryonic-like stem cells.

Authors:  D M Shin; E K Zuba-Surma; W Wu; J Ratajczak; M Wysoczynski; M Z Ratajczak; M Kucia
Journal:  Leukemia       Date:  2009-07-30       Impact factor: 11.528

10.  An intensified systemic trafficking of bone marrow-derived stem/progenitor cells in patients with pancreatic cancer.

Authors:  Teresa Starzyńska; Krzysztof Dąbkowski; Wojciech Błogowski; Ewa Zuba-Surma; Marta Budkowska; Daria Sałata; Barbara Dołęgowska; Wojciech Marlicz; Jerzy Lubikowski; Mariusz Z Ratajczak
Journal:  J Cell Mol Med       Date:  2013-05-15       Impact factor: 5.310

View more
  10 in total

1.  Endothelial Colony-Forming Cells Do Not Participate to Fibrogenesis in a Bleomycin-Induced Pulmonary Fibrosis Model in Nude Mice.

Authors:  Adeline Blandinières; Thomas Gille; Jérémy Sadoine; Ivan Bièche; Lofti Slimani; Blandine Dizier; Pascale Gaussem; Catherine Chaussain; Carole Planes; Peter Dorfmüller; Dominique Israël-Biet; David M Smadja
Journal:  Stem Cell Rev Rep       Date:  2018-12       Impact factor: 5.739

2.  Circulating Stem Cells in Physiology and Pathology - Recent Studies Published in Stem Cell Reviews and Reports.

Authors:  Mariusz Z Ratajczak
Journal:  Stem Cell Rev Rep       Date:  2018-10       Impact factor: 5.739

3.  Industrialized GMP Production of CD34+ Cells (ProtheraCytes®) at Clinical Scale for Treatment of Ischemic Cardiac Diseases Is Feasible and Safe.

Authors:  Philippe Hénon; Marc Kowalczyk; Anne Aries; Christine Vignon; Guillaume Trébuchet; Rachid Lahlil
Journal:  Stem Cell Rev Rep       Date:  2022-04-14       Impact factor: 6.692

4.  Novel View on Umbilical Cord Blood and Maternal Peripheral Blood-an Evidence for an Increase in the Number of Circulating Stem Cells on Both Sides of the Fetal-Maternal Circulation Barrier.

Authors:  Katarzyna Sielatycka; Agata Poniewierska-Baran; Karolina Nurek; Andrzej Torbé; Mariusz Z Ratajczak
Journal:  Stem Cell Rev Rep       Date:  2017-12       Impact factor: 5.739

5.  VSELs Maintain their Pluripotency and Competence to Differentiate after Enhanced Ex Vivo Expansion.

Authors:  Rachid Lahlil; Maurice Scrofani; Romain Barbet; Céline Tancredi; Anne Aries; Philippe Hénon
Journal:  Stem Cell Rev Rep       Date:  2018-08       Impact factor: 5.739

Review 6.  Elevated Numbers of Circulating Very Small Embryonic-Like Stem Cells (VSELs) and Intermediate CD14++CD16+ Monocytes in IgA Nephropathy.

Authors:  Andrzej Eljaszewicz; Katarzyna Kleina; Kamil Grubczak; Urszula Radzikowska; Paula Zembko; Paulina Kaczmarczyk; Marlena Tynecka; Karolina Dworzanczyk; Beata Naumnik; Marcin Moniuszko
Journal:  Stem Cell Rev Rep       Date:  2018-10       Impact factor: 5.739

7.  A Circadian Rhythm in both Complement Cascade (ComC) Activation and Sphingosine-1-Phosphate (S1P) Levels in Human Peripheral Blood Supports a Role for the ComC-S1P Axis in Circadian Changes in the Number of Stem Cells Circulating in Peripheral Blood.

Authors:  Marta Budkowska; Ewa Ostrycharz; Adrianna Wojtowicz; Zuzanna Marcinowska; Jarosław Woźniak; Mariusz Z Ratajczak; Barbara Dołęgowska
Journal:  Stem Cell Rev Rep       Date:  2018-10       Impact factor: 5.739

8.  Is COVID-19 a New Hematologic Disease?

Authors:  Benjamin Debuc; David M Smadja
Journal:  Stem Cell Rev Rep       Date:  2021-02       Impact factor: 5.739

9.  Decellularized human ovarian scaffold based on a sodium lauryl ester sulfate (SLES)-treated protocol, as a natural three-dimensional scaffold for construction of bioengineered ovaries.

Authors:  Ashraf Hassanpour; Tahereh Talaei-Khozani; Elias Kargar-Abarghouei; Vahid Razban; Zahra Vojdani
Journal:  Stem Cell Res Ther       Date:  2018-09-26       Impact factor: 6.832

10.  Role of Adult Tissue-Derived Pluripotent Stem Cells in Bone Regeneration.

Authors:  Liudmila Leppik; K Sielatycka; D Henrich; Z Han; H Wang; M J Eischen-Loges; K M C Oliveira; M B Bhavsar; M Z Ratajczak; J H Barker
Journal:  Stem Cell Rev Rep       Date:  2020-02       Impact factor: 5.739

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.